Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension [clinicaltrials:NCT00136851]

Bio2RDF uri

Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension [clinicaltrials:NCT00136851]

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

http://bio2rdf.org/clinicaltrials:NCT00136851

Bio2RDF identifier

NCT00136851

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT00136851

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT00136851

actual enrollment [clinicaltrials_vocabulary:actual-enrollment]

259

http://www.w3.org/2001/XMLSchema#integer

authority [clinicaltrials_vocabulary:authority]

clinicaltrials_resource:d942c8692d257084abf3ac87279faff6

brief summary [clinicaltrials_vocabulary:brief-summary]

This trial is designed ...... tment of severe hypertension.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Study Comparing the Efficacy o ...... eatment of Severe Hypertension

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Percentage of subjects achieving blood pressure goal which is defined as < 140/90 mm Hg, or < 130/80 mm Hg in subjects with diabetes after 4 weeks [clinicaltrials_resource:d63c4fa4a30b43506bc7af88775628cd]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Percentage of subjects achieving blood pressure goal which is defined as < 140/90 mm Hg, or < 130/80 mm Hg in subjects with diabetes after 4 weeks [clinicaltrials_resource:1edc6a938ac0bfd051373541fa7aa357]

Percentage of subjects achieving blood pressure goal which is defined as < 140/90 mm Hg, or < 130/80 mm Hg in subjects with diabetes after 4 weeks [clinicaltrials_resource:9ef8684c6f4c9dbea6cc2aaa39ca5a76]

Percentage of subjects achieving blood pressure goal which is defined as < 140/90 mm Hg, or < 130/80 mm Hg in subjects with diabetes after 4 weeks [clinicaltrials_resource:ea006e1750b930200e8fc705812d7cad]

Percentage of subjects achieving blood pressure goal which is defined as < 140/90 mm Hg, or < 130/80 mm Hg in subjects with diabetes after 4 weeks [clinicaltrials_resource:f782ca7a26d821467496d09f3aa0a3c5]

completion date [clinicaltrials_vocabulary:completion-date]

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT00136851 [clinicaltrials_resource:63d5e9c2f397c28670b1273eddc85cf1]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2005-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

intervention [clinicaltrials_vocabulary:intervention]

amlodipine besylate/benazepril hydrochloride [clinicaltrials_resource:d658f1a8a8bd2565107c8fb36db7d173]

intervention browse [clinicaltrials_vocabulary:intervention-browse]

Benazepril [clinicaltrials_resource:0bd180a074dcca682553978b09856e2b]

Amlodipine [clinicaltrials_resource:fcc2b9e33b7f430eef785717c9c26b32]

keyword [clinicaltrials_vocabulary:keyword]

Hypertension

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2011-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

Novartis Pharmaceuticals [clinicaltrials_resource:6c46b84d98e818ca1d19723a0f4ae0c2]

location [clinicaltrials_vocabulary:location]

Novartis Pharmaceuticals [clinicaltrials_resource:d28184c892b63a38ec1af3826692b814]

nct id [clinicaltrials_vocabulary:nct-id]

NCT00136851

http://www.w3.org/2001/XMLSchema#string

official title [clinicaltrials_vocabulary:official-title]

A 6-Week Multi-center, Randomi ...... eatment of Severe Hypertension

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

CCIB002FUS19

http://www.w3.org/2001/XMLSchema#string

overall official [clinicaltrials_vocabulary:overall-official]

Novartis Pharmaceuticals [clinicaltrials_resource:28e3bed31c31bd9e070818cad8a0e3d3]

overall status [clinicaltrials_vocabulary:overall-status]

Completed [clinicaltrials_resource:07ca5050e697392c9ed47e6453f1453f]

oversight [clinicaltrials_vocabulary:oversight]

United States: Food and Drug Administration [clinicaltrials_resource:77fa11db9aea1d8cd0ff35db5bc538f2]

phase [clinicaltrials_vocabulary:phase]

Phase 4 [clinicaltrials_resource:ec41833bc88cd90619c4d85c549688bd]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

responsible party [clinicaltrials_vocabulary:responsible-party]

[clinicaltrials_resource:dbd41868ee618d3e64daa1adf8c3a8a0]

source [clinicaltrials_vocabulary:source]

Novartis [clinicaltrials_resource:4b711ffdbe8af5c8f3f9c53da46d83fa]

start date [clinicaltrials_vocabulary:start-date]

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT00136851 study design [clinicaltrials_resource:03119faebea88f5a02ef45d5fd97bebe]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT00136851

verification date [clinicaltrials_vocabulary:verification-date]

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT00136851

http://www.w3.org/2001/XMLSchema#string

title

Study Comparing the Efficacy o ...... eatment of Severe Hypertension

@en

inDataset

clinicaltrials_resource:bio2rdf.dataset.clinicaltrials.R3

type

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

label

Study Comparing the Efficacy o ...... n [clinicaltrials:NCT00136851]

@en